JP2022510008A5 - - Google Patents
Info
- Publication number
- JP2022510008A5 JP2022510008A5 JP2021531638A JP2021531638A JP2022510008A5 JP 2022510008 A5 JP2022510008 A5 JP 2022510008A5 JP 2021531638 A JP2021531638 A JP 2021531638A JP 2021531638 A JP2021531638 A JP 2021531638A JP 2022510008 A5 JP2022510008 A5 JP 2022510008A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- pharmaceutical composition
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862774688P | 2018-12-03 | 2018-12-03 | |
| US62/774,688 | 2018-12-03 | ||
| US201962798713P | 2019-01-30 | 2019-01-30 | |
| US201962798711P | 2019-01-30 | 2019-01-30 | |
| US201962798710P | 2019-01-30 | 2019-01-30 | |
| US62/798,711 | 2019-01-30 | ||
| US62/798,710 | 2019-01-30 | ||
| US62/798,713 | 2019-01-30 | ||
| PCT/US2019/064228 WO2020117799A1 (en) | 2018-12-03 | 2019-12-03 | Carborane compounds, carborane analogs, and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022510008A JP2022510008A (ja) | 2022-01-25 |
| JP2022510008A5 true JP2022510008A5 (enExample) | 2022-12-08 |
| JP7644006B2 JP7644006B2 (ja) | 2025-03-11 |
Family
ID=70974874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531638A Active JP7644006B2 (ja) | 2018-12-03 | 2019-12-03 | カルボラン化合物、カルボラン類似体、およびその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20220040210A1 (enExample) |
| EP (1) | EP3890750A4 (enExample) |
| JP (1) | JP7644006B2 (enExample) |
| CN (1) | CN113347979B (enExample) |
| AU (1) | AU2019393785A1 (enExample) |
| CA (1) | CA3122029A1 (enExample) |
| WO (1) | WO2020117799A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115515580A (zh) * | 2020-03-11 | 2022-12-23 | 俄亥俄州国家创新基金会 | 使用碳硼烷和碳硼烷类似物调节t细胞活化的方法 |
| WO2023239764A1 (en) * | 2022-06-08 | 2023-12-14 | Ohio State Innovation Foundation | Methods and compositions for treating lupus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000043016A1 (en) * | 1999-01-22 | 2000-07-27 | Institute Of Medicinal Molecular Design. Inc. | DICARBA-closo-DODECABORANE DERIVATIVES |
| KR100884489B1 (ko) * | 2007-02-21 | 2009-02-18 | 원광대학교산학협력단 | 1,3,5-트리아진-4-일-디카르보-클로소-도데카보란 유도체,이의 제조방법 및 이를 포함하는 약학적 조성물 |
| ES2700141T3 (es) * | 2007-08-02 | 2019-02-14 | Gilead Biologics Inc | Anticuerpos inhibidores LOXL2 y usos de los mismos |
| DE102007038930B4 (de) * | 2007-08-13 | 2013-12-05 | Universität Leipzig | Neue chemische Verbindung und deren Verwendung in der Medizin, insbesondere für die Verwendung in der Tumortherapie |
| JP2010208996A (ja) * | 2009-03-11 | 2010-09-24 | Okayama Univ | 置換フェニルプロピオン酸誘導体を含有する医薬組成物 |
| CZ2011676A3 (cs) * | 2011-10-24 | 2013-05-02 | Ústav organické chemie a biochemie Akademie ved CR, v.v.i. | Inhibitory karbonické anhydrasy, zpusob jejich prípravy |
| CN108884124A (zh) * | 2015-09-17 | 2018-11-23 | 俄亥俄州创新基金会 | 碳硼烷化合物及其使用方法 |
-
2019
- 2019-12-03 CA CA3122029A patent/CA3122029A1/en active Pending
- 2019-12-03 CN CN201980090221.3A patent/CN113347979B/zh active Active
- 2019-12-03 EP EP19894187.4A patent/EP3890750A4/en active Pending
- 2019-12-03 US US17/299,618 patent/US20220040210A1/en not_active Abandoned
- 2019-12-03 JP JP2021531638A patent/JP7644006B2/ja active Active
- 2019-12-03 WO PCT/US2019/064228 patent/WO2020117799A1/en not_active Ceased
- 2019-12-03 AU AU2019393785A patent/AU2019393785A1/en not_active Abandoned
-
2025
- 2025-05-22 US US19/215,589 patent/US20250281515A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3214530A1 (en) | Combination therapies using prmt5 inhibitors for the treatment of cancer | |
| ES2880999T3 (es) | Sal de tosilato cristalina de un inhibidor selectivo de PI3K delta para uso en formulaciones farmacéuticas | |
| CA3214535A1 (en) | Combination therapies using prmt5 inhibitors for the treatment of cancer | |
| JP7362749B2 (ja) | ポリエチレングリコール抱合薬ならびにその製造方法および使用 | |
| WO2019190266A1 (ko) | 전립선암 진단 및 치료를 위한 psma-표적 방사성의약품 | |
| WO2009121228A2 (zh) | 鲁比前列酮晶体、其制备方法及用途 | |
| CN113402560A (zh) | 具有口服生物利用率的五氮杂大环状环络合物 | |
| CN117567309B (zh) | 一种可电离脂质、阳离子脂肽、脂质纳米颗粒及其制备方法与应用 | |
| JP2022510008A5 (enExample) | ||
| WO2022242488A1 (zh) | 聚乙二醇偶联药物及其用途 | |
| CN103193601A (zh) | 2-苯基萘衍生物及其在制备抗肿瘤药物中的应用 | |
| CN108299531A (zh) | 甲哌泰万菌素可药用盐及其制备方法 | |
| CA3233157A1 (en) | Combination therapies using prmt5 inhibitors for the treatment of cancer | |
| CN113811302B (zh) | 激酶抑制剂的用途 | |
| CN117820149B (zh) | 可电离脂质化合物 | |
| TWI905319B (zh) | Ａｒｂ代謝產物與ｎｅｐ抑制劑的複合物在製備用於預防和/或治療腎病的藥物中的用途 | |
| JP7664429B2 (ja) | Ｆｇｆｒ４選択的阻害剤の塩及びその製造方法と用途 | |
| EP4580628A1 (en) | Combination therapies using prmt5 inhibitors and bcl-2 family inhibitors for the treatment of cancer | |
| CN105753869B (zh) | 一种cdk抑制剂和mek抑制剂的共晶及其制备方法 | |
| WO2023160702A1 (zh) | 氨基脂质化合物、其制备方法、组合物和应用 | |
| WO2008154801A1 (en) | A trans-cinnamic acid derivative, its preparation method and the use | |
| CN102942497B (zh) | 氨基取代羧酸类化合物的制备及其应用 | |
| JP2016539077A (ja) | ７−α−［９−（４，４，５，５，５−ペンタフルオロ−ペンチル−スルフィニル）ノニル］−エストラ−１，３，５（１０）−トリエン−３，１７β−ジオール及びその誘導体の使用 | |
| WO2011147254A1 (zh) | 苯丁酰基姜黄素衍生物及其在制备抗肿瘤药物中的应用 | |
| KR102959367B1 (ko) | Ep4 길항제 화합물, 이의 염, 다형체 및 용도 |